AzTrials
AzTrials

Medical ComplexityASKidsNCT07127666

ASKids! Inpatient Agenda-Setting Study for Hospitalized Children With Medical Complexity

A study testing Structured Agenda-Setting Tool in people with Medical Complexity, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this open pilot is to co-design and test a clinical agenda-setting intervention in the inpatient pediatric environment. We pilot a co-designed structured agenda-setting intervention (SAS) for multi-family meetings about children with medical complexity. Read more about this study

Who is it for?
Ages 7 years and older
Conditions the study is for
Medical Complexity
What is being tested?
Structured Agenda-Setting Tool
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
1 Aug 2026to Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Pediatric Inpatients: Children aged 7-17 years
  • Can communicate in English
  • Able to provide verbal assent, with consent from their care partner
  • Dartmouth Hitchcock Medical Center pediatric patient who currently or has recently (within the last 3 months) been hospitalized with a length of stay of 4≥ days Care Partners: - Adults aged 18≥ years
  • Can communicate in English
  • Able to provide verbal consent
  • Care partners of Dartmouth Hitchcock Medical Center pediatric patients who are currently or have recently (within the last 3 months) been hospitalized with a length of stay of 4≥ days

Who cannot join

  • For pediatric inpatients, children < aged 7
  • For care partners, children aged <18 years
  • Cannot communicate in English
  • For pediatric inpatients, unable to provide verbal assent
  • For care partners, unable to provide consent
  • Prisoners

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Catherine H. Saunders, PhD, MPH contact

603-653-3436

Catherine.Hylas.Saunders@dartmouth.edu

Anne E Dade, MPP contact

anne.e.dade@dartmouth.edu

United States1 site
  • Dartmouth Hitchcock

    Lebanon, New Hampshire, 03756-1000

Other trials in United States

About this study

Official title: Centering Children and Care Partners in Complex Pediatric Hospital Stays: Evaluation of a Structured Inpatient Agenda-setting Intervention for Multidisciplinary Family Meetings

The goal of this open pilot is to co-design and test a clinical agenda-setting intervention in the inpatient pediatric environment. We pilot a co-designed structured agenda-setting intervention (SAS) for multi-family meetings about children with medical complexity. Our open pilot will evaluate the feasibility and acceptability of using the SAS during routine multidisciplinary family meetings (MFM) at Dartmouth Hitchcock Medical Center. By doing an open pilot, researchers will learn if the agenda-setting instrument and implementation process are feasible and acceptable to patients, their care partner and their clinicians.

Read the detailed description

In this open pilot, the researchers will adapt and administer a novel structured agenda-setting tool (SAS) in the inpatient pediatric environment. The researchers will determine if their procedures for screening eligible participants, administering the intervention, and administering outcome and other questionnaires are appropriate. Learnings from the open pilot will feed forward into procedures in applications for larger trials of the intervention.

This study only has one arm, the intervention arm. The intervention, the co-adapted SAS, will be administered to all enrolled participants.

Future Directions: This open pilot will provide preliminary data for potential future larger trials.

Being tested
Structured Agenda-Setting Tool
Keywords
clinical agenda-setting, pediatric inpatient care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Structured Agenda-Setting ToolOther

    We are testing a novel clinical visit agenda-setting intervention developed through participatory research methods for the pediatric inpatient environment. This structured agenda-setting (SAS) intervention will be co-designed to include structured discussion topic areas with the option for patients (when appropriate) and their care partners to consider and indicate their priority topic areas and take notes before, during, and after a clinical visit.

Study groups in NCT07127666
Study groupRoleWhat they receive
Treatment (Implements Structured Agenda-Setting Intervention)ExperimentalThe study team will implement a structured clinical visit agenda-setting (SAS) intervention customized for the pediatric inpatient environment.
Receives: Other: Structured Agenda-Setting Tool

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Primary Outcome: Feasibility

    Our primary outcome will be feasibility, assessed by the proportion of patients who receive the intervention.

    Measured: Immediately after intervention delivery

Secondary outcomes (1)
  1. Primary Process Outcome: Enrollment Rate

    Description: As measured by participant enrollment in REDCap.

    Measured: Immediately after intervention delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2025
  2. Study start1 Aug 2026 (estimated)
  3. Primary completionNov 2026 (estimated)
  4. Study completionDec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07127666
Sponsor's protocol ID
STUDY02002855
Other IDs
UM1TR004772
Acronym
ASKids
Status last verified
Jul 2026
First submitted
5 Aug 2025
Last updated
22 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: We will de-identified quantitative open pilot data available.

Publications

  • Sierpe A, Yen RW, Stevens G, Van Citters AD, Elwyn G, Saunders CH. Agenda-setting in the clinical encounter: A systematic review protocol. PLoS One. 2024 Oct 24;19(10):e0312613. doi: 10.1371/journal.pone.0312613. eCollection 2024.

    PubMed 39446854
  • Saunders CH, Durand MA, Kirkland KB, MacMartin MA, Barnato AE, Elwyn G. Psychometric assessment of the consideRATE questions, a new measure of serious illness experience, with an online simulation study. Patient Educ Couns. 2022 Jul;105(7):2581-2589. doi: 10.1016/j.pec.2022.01.002. Epub 2022 Jan 22.

    PubMed 35260261

Questions about this trial

What is this clinical trial studying?

A study testing Structured Agenda-Setting Tool in people with Medical Complexity, run by Dartmouth-Hitchcock Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 22 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Catherine H. Saunders, PhD, MPH (603-653-3436, Catherine.Hylas.Saunders@dartmouth.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Primary Outcome: Feasibility (time frame: Immediately after intervention delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07127666, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in